IMPACT OF RITUXIMAB ON IMMUNE STATUS FOLLOWING THERAPY IN CHILDREN AND ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN LYMPHOMA: RESULTS OF THE INTER-B-NHL RITUX 2010 TRIAL

被引：0
|
作者：
Alexander, S. [1 ]
Auperin, A. [2 ]
Bomken, S. [3 ]
Csoka, M. [4 ]
Kazanowska, B. [5 ]
Chiang, A. [6 ]
Andres Moreno, M. [7 ]
Uyttebroeck, A. [8 ]
Burke, A. [9 ]
Zsiros, J. [10 ]
Pillon, M. [11 ]
Bollard, C. [12 ,13 ]
Barkauskas, D. [14 ]
Wheatley, K. [15 ]
Patte, C. [16 ,17 ]
Gross, T. [18 ]
Minard-Colin, V. [16 ,17 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[2] Univ Paris Saclay, Unit Biostat & Epidemiol, Gustave Roussy, Villejuif, France
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Paediat Haematol & Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Semmelweis Univ, Dept Pediat Hematol & Oncol, Budapest, Hungary
[5] Wroclaw Med Univ, Dept Pediat Bone Marrow Transplantat Oncol & Hema, Wroclaw, Poland
[6] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Peoples R China
[7] Univ Valencia, Dept Pediat Hematol & Oncol, Valencia, Spain
[8] Univ Hosp Leuven, Dept Pediat Hematol & Oncol, Leuven, Belgium
[9] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Paediat Haematol Oncol & Palliat Care, Cambridge, England
[10] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[11] Univ Padua, Dept Pediat Hematol & Oncol, Padua, Italy
[12] George Washington Univ, Ctr Canc & Immunol Res, Washington, DC USA
[13] George Washington Univ, Washington, DC USA
[14] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA
[15] Royal Marsden NHS Fdn Trust, Dept Histopathol, London, England
[16] Univ Paris Saclay, Gustave Roussy, Dept Pediat, Villejuif, France
[17] Univ Paris Saclay, Gustave Roussy, Dept Adolescent Oncol, Villejuif, France
[18] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA
来源：
LEUKEMIA RESEARCH | 2022年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
011
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [31] The role of 18F-FDG-PET/CT for early response evaluation in pediatric high-grade B-cell lymphoma patients treated with the inter-B-NHL ritux 2010 protocol
    Berger-Achituv, Sivan
    Bella, Bielorai
    Hanna, Golan
    Lerman, Hedva
    Even-Sapir, Einat
    Rosenfeld-Keidar, Hila
    Dvir, Rina
    Levin, Dror
    Amos, Toren
    Elhasid, Ronit
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 69 - 70
  • [32] RITUXIMAB IN COMBINATION WITH STANDARD CHEMOTHERAPY FOR HIGH-RISK MATURE B-CELL NON-HODKIN′S LYMPHOMA IN CHILDREN: THE JPLSG B-NH14 TRIAL
    Mori, Tetsuya
    Osumi, Tomoo
    Kada, Akiko
    Saito, Akiko
    Nakazawa, Atsuko
    Kobayashi, Ryoji
    Sekimizu, Masahiro
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S72 - S72
  • [33] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Phase II study of oral Fludarabine (FAMP) in combination with rituximab in indolent B-cell non-hodgkin lymphoma (B-NHL)
    Ishizawa, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Itoh, Kuniaki
    Aorishima, Yasuo
    Ando, Kiyoshi
    Yamamoto, Joji
    Watanabe, Takashi
    Uchida, Toshiki
    Nakata, Masanobu
    Hayashi, Masaki
    Hotta, Tomomitsu
    BLOOD, 2007, 110 (11) : 387A - 387A
  • [35] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [36] Menopausal hormone therapy and B-cell non-Hodgkin lymphoma (NHL) risk in the Los Angeles County NHL Case-Control Study
    Wang, Sophia S.
    Luo, Jianning
    Sullivan-Halley, Jane
    Lu, Yani
    James, Lacey V., Jr.
    Cozen, Wendy
    Bernstein, Leslie
    CANCER RESEARCH, 2014, 74 (19)
  • [37] A study of rituximab and ifosfamide, carboplatin, etoposide (ICE) chemotherapy in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute lymphoblastic leukemia (B-ALL). A children's oncology group report
    Griffin, T.
    Weitzman, S.
    Weinstein, H.
    Chang, M.
    Hutchison, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [38] High Dose Methotrexate and Survival Outcomes for Pediatric Mature B-Cell Non-Hodgkin Lymphoma (NHL) in Malawi: A Single Institution Study
    Wanda, W.
    Manda, G.
    Huibers, M.
    Mtete, I.
    Butia, M.
    Wasswa, P.
    Mehta, P.
    Ozuah, N.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S272 - S273
  • [39] A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma
    Torka, Pallawi
    Patel, Priyank
    Tan, Wei
    Wilding, Gregory
    Bhat, Seema A.
    Czuczman, Myron S.
    Lee, Kelvin P.
    Deeb, George
    Neppalli, Vishala
    Mavis, Cory
    Wallace, Paul
    Hernandez-Ilizaliturri, Francisco J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : E51 - E60
  • [40] Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
    Cairo, Mitchell S.
    Gerrard, Mary
    Sposto, Richard
    Auperin, Anne
    Pinkerton, C. Ross
    Michon, Jean
    Weston, Claire
    Perkins, Sherrie L.
    Raphael, Martine
    McCarthy, Keith
    Patte, Catherine
    BLOOD, 2007, 109 (07) : 2736 - 2743
12345